Taxane and platinum-based chemotherapeutic agents
This page covers all Taxane and platinum-based chemotherapeutic agents drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Microtubules and DNA.
Targets
Phase 2 pipeline (1)
- CCRT with weekly docetaxel & cisplatin · Samsung Medical Center · Oncology
Docetaxel inhibits microtubule dynamics, disrupting cell division, while cisplatin induces DNA crosslinks, causing cell death.
Patent intelligence
- taxane and platinum based chemotherapeutic agents patent landscape — aggregated cliff calendar, attackable patents, originator estates